BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11598453)

  • 1. Genetic aberrations of NAT2 and chromosome 8: their association with progression in transitional cell carcinoma of the urinary bladder.
    Watters AD; Stacey MW; Going JJ; Grigor KM; Cooke TG; Sim E; Bartlett JM
    Urol Int; 2001; 67(3):235-9. PubMed ID: 11598453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression to detrusor-muscle invasion in bladder carcinoma is associated with polysomy of chromosomes 1 and 8 in recurrent pTa/pT1 tumours.
    Watters AD; Going JJ; Grigor KM; Bartlett JM
    Eur J Cancer; 2002 Aug; 38(12):1593-9. PubMed ID: 12142047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer.
    Watters AD; Latif Z; Forsyth A; Dunn I; Underwood MA; Grigor KM; Bartlett JM
    Br J Cancer; 2002 Sep; 87(6):654-8. PubMed ID: 12237776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes for human arylamine N-acetyltransferases in relation to loss of the short arm of chromosome 8 in bladder cancer.
    Thygesen P; Risch A; Stacey M; Fakis G; Giannoulis F; Takle L; Knowles M; Sim E
    Pharmacogenetics; 1999 Feb; 9(1):1-8. PubMed ID: 10208636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylamine N-acetyltransferase type 2 (NAT2), chromosome 8 aneuploidy, and identification of a novel NAT1 cosmid clone: an investigation in bladder cancer by interphase FISH.
    Stacey M; Matas N; Drake M; Payton M; Fakis G; Greenland J; Sim E
    Genes Chromosomes Cancer; 1999 Aug; 25(4):376-83. PubMed ID: 10398432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Mess F; Böhle A; Feller AC
    Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer.
    Simon R; Bürger H; Brinkschmidt C; Böcker W; Hertle L; Terpe HJ
    J Pathol; 1998 Aug; 185(4):345-51. PubMed ID: 9828832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.
    Eleuteri P; Grollino MG; Pomponi D; De Vita R
    Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer.
    Neuhaus M; Wagner U; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Moch H; Mihatsch MJ; Gasser TC; Sauter G
    Hum Pathol; 1999 Jan; 30(1):81-6. PubMed ID: 9923932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Numerical aberrations of chromosome 8 and allelic loss at 8p in non-muscle-invasive urothelial carcinomas of the urinary bladder.
    Erbersdobler A; Kaiser H; Friedrich MG; Henke RP
    Eur Urol; 2000 Nov; 38(5):590-6. PubMed ID: 11096241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma.
    Panani AD; Roussos C
    Anticancer Res; 2006; 26(1A):319-23. PubMed ID: 16475713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
    Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
    Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder.
    Watters AD; Ballantyne SA; Going JJ; Grigor KM; Bartlett JM
    BJU Int; 2000 Jan; 85(1):42-7. PubMed ID: 10619944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
    Bartlett JM; Watters AD; Ballantyne SA; Going JJ; Grigor KM; Cooke TG
    Br J Cancer; 1998 Jun; 77(12):2193-8. PubMed ID: 9649132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
    Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
    Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
    Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
    Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphase cytogenetics of bladder cancer progression: relationship between aneusomy, DNA ploidy pattern, histopathology, and clinical outcome.
    Cianciulli AM; Bovani R; Leonardo F; Antenucci A; Gandolfo GM; Giannarelli D; Leonardo C; Iori F; Laurenti C
    Int J Clin Lab Res; 2000; 30(1):5-11. PubMed ID: 10984125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.